Fed. Circ. Revives 1 Of 2 Lovenox Patent Suits
The Federal Circuit on Tuesday ruled that generic manufacturers Teva and Amphastar did not infringe a testing patent for the blood thinner Lovenox asserted by Momenta Pharmaceuticals under one statute, but...To view the full article, register now.
Already a subscriber? Click here to view full article